A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.

The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved ...

CMS Administrator Dr. Oz proposes deep cuts to the 340B drug program to lower Medicare costs. Learn how this affects ...

The breadth of the proposal suggests that many organizations will need to reassess existing policies, contractual ...

This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to utilization increases, not price. Payers have struggled with the increasing ...

Hospital groups warn the 340B rebate pilot would force safety net providers to front tens of millions of dollars for drugs and drain resources from vulnerable patients. The American Hospital ...

“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...

In recent weeks, two competing visions have emerged to legislatively modernize the federal 340B drug discount program (“340B Program”).

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

On July 31, 2025, the Health Resources and Services Administration (HRSA) released long-awaited guidance establishing a 340B Rebate Model Pilot Program (Pilot Program). The announcement marks a ...

AHA responds to Information Collection Request about the Health Resources and Services Administration’s proposed 340B Rebate Model Program.

Halo340B today called on Federally Qualified Health Centers and other 340B covered entities to take a more strategic and mission-driven approach to understanding their 340B gross-to-net performance.